0001766366-23-000002.txt : 20231221 0001766366-23-000002.hdr.sgml : 20231221 20231220182719 ACCESSION NUMBER: 0001766366-23-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231221 DATE AS OF CHANGE: 20231220 EFFECTIVENESS DATE: 20231221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allay Therapeutics, Inc. CENTRAL INDEX KEY: 0001766366 ORGANIZATION NAME: IRS NUMBER: 814790967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-413904 FILM NUMBER: 231502442 BUSINESS ADDRESS: STREET 1: 2720 ZANKER ROAD CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 650-514-6284 MAIL ADDRESS: STREET 1: 2720 ZANKER ROAD CITY: SAN JOSE STATE: CA ZIP: 95134 FORMER COMPANY: FORMER CONFORMED NAME: Foundry Therapeutics 1, Inc. DATE OF NAME CHANGE: 20190129 D/A 1 primary_doc.xml X0708 D/A LIVE 0001766366 Allay Therapeutics, Inc. 2720 ZANKER ROAD SAN JOSE CA CALIFORNIA 95134 650-514-6284 DELAWARE Foundry Therapeutics 1, Inc. Corporation true Michael A. Carusi c/o Allay Therapeutics, Inc. 2720 Zanker Road San Jose CA CALIFORNIA 95134 Director Mark Deem c/o Allay Therapeutics, Inc. 2720 Zanker Road San Jose CA CALIFORNIA 95134 Director Nicole Vitullo c/o Allay Therapeutics, Inc. 2720 Zanker Road San Jose CA CALIFORNIA 95134 Director Josh Makower c/o Allay Therapeutics, Inc. 2720 Zanker Road San Jose CA CALIFORNIA 95134 Director Tak Cheung c/o Allay Therapeutics, Inc. 2720 Zanker Road San Jose CA CALIFORNIA 95134 Director Leighton Read c/o Allay Therapeutics, Inc. 2720 Zanker Road San Jose CA CALIFORNIA 95134 Director Adam Gridley c/o Allay Therapeutics, Inc. 2720 Zanker Road San Jose CA CALIFORNIA 95134 Executive Officer Director Paul McCreadie c/o Allay Therapeutics, Inc. 2720 Zanker Road San Jose CA CALIFORNIA 95134 Director Biotechnology Decline to Disclose 06b true 0001766366-21-000004 2021-09-09 true true false 1 86890346 86890346 0 false 22 0 true 0 true 0 true false Allay Therapeutics, Inc. /s/ Adam Gridley Adam Gridley Chief Executive Officer 2023-12-20